NCT00806546View on ClinicalTrials.gov

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

PHASE3CompletedINTERVENTIONAL

Enrollment

514

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Migraine Disorders

Interventions

DRUG

NP101

NP101 study patch four hour application

Trial Locations (31)

Unknown

Phoenix

Scottsdale

Irvine

Newport Beach

San Francisco

Santa Monica

Walnut Creek

Fairfield

Hallandale

Ocala

Sunrise

Atlanta

Decatur

Savannah

Crestview Hills

Ann Arbor

St Louis

Mount Vernon

Plainview

Greensboro

Cincinnati

Cleveland

Oklahoma City

Philadelphia

Pittsburgh

Clarksville

Dallas

San Antonio

Alexandria

Virginia Beach

Seattle

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NuPathe Inc.

INDUSTRY